HSV-2 gG

Herpes Simplex Virus-2 gG Recombinant
Cat. No.
BT18968
Source
Synonyms
Appearance
Sterile Filtered clear solution.
Purity
HSV-2 gG protein is >95% pure as determined by 10% PAGE (coomassie staining).
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

The E.Coli derived recombinant protein contains the HSV-2 gG immunodominant regions, 525-578 amino acids, the total MW is 32,100 Dalton, fused with 26 kDa GST-tag.

Product Specs

Introduction
Herpes simplex virus (HSV) enters host cells through a multi-step process involving interactions between viral glycoproteins and cell surface receptors. The virus's outer envelope, studded with glycoproteins, binds to specific receptors on the cell surface. This binding triggers the fusion of the viral envelope with the cell membrane, creating a pore. Through this pore, the virus gains entry into the host cell. The stages of HSV entry mirror those of other viruses. Initially, complementary receptors on the virus and cell surface facilitate membrane proximity. Subsequently, the two membranes begin to merge, forming a hemifusion intermediate. Finally, a stable entry pore is established, allowing the viral contents to enter the host cell.
Description
This recombinant protein, derived from E. coli, encompasses the immunodominant regions of HSV-2 gG (amino acids 525-578). With a total molecular weight of 32.1 kDa, it includes a 26 kDa GST-tag.
Purity
The purity of the HSV-2 gG protein exceeds 95%, as determined by 10% SDS-PAGE analysis with Coomassie blue staining.
Physical Appearance
The product is a clear, sterile-filtered solution.
Formulation
The protein is supplied in a buffer containing 25mM Tris (pH 8), 1.5M Urea, and 50% glycerol.
Stability
For optimal storage, the HSV-2 gG protein should be stored at temperatures below -18°C. While it can remain stable at 4°C for up to one week, it is recommended to minimize freeze-thaw cycles to preserve protein integrity.
Purification Method
HSV-2 gG protein was purified by proprietary chromatographic technique.
Specificity
Immunoreactive with sera of HSV-infected individuals.

Product Science Overview

Introduction

Herpes Simplex Virus-2 (HSV-2) is a significant human pathogen primarily associated with genital infections. It is a member of the Herpesviridae family, which also includes HSV-1, known for causing orofacial lesions. HSV-2 infections are widespread and can lead to severe health complications, including neonatal herpes, encephalitis, and an increased risk of HIV transmission.

Glycoprotein G (gG)

Glycoprotein G (gG) is one of the envelope glycoproteins of HSV-2. It plays a crucial role in the virus’s ability to infect host cells and evade the immune system. The gG protein is unique to HSV-2 and is not found in HSV-1, making it a valuable target for diagnostic assays and vaccine development.

Recombinant gG

Recombinant gG refers to the glycoprotein G that has been produced using recombinant DNA technology. This involves inserting the gene encoding gG into a suitable expression system, such as bacteria, yeast, or mammalian cells, to produce the protein in large quantities. Recombinant gG is used in various applications, including:

  1. Diagnostic Assays: Recombinant gG is utilized in serological tests to detect HSV-2-specific antibodies in patient samples. These tests are essential for diagnosing HSV-2 infections, especially in asymptomatic individuals.
  2. Vaccine Development: The unique properties of gG make it a promising candidate for vaccine development. Researchers are exploring the use of recombinant gG to elicit an immune response that can protect against HSV-2 infection.
  3. Research: Recombinant gG is used in research to study the structure and function of the glycoprotein, as well as its interactions with the host immune system.
Production of Recombinant gG

The production of recombinant gG involves several steps:

  1. Gene Cloning: The gene encoding gG is cloned into an expression vector, which is a DNA molecule used to introduce the gene into the host cells.
  2. Transformation: The expression vector is introduced into the host cells, which can be bacteria, yeast, or mammalian cells, depending on the desired expression system.
  3. Protein Expression: The host cells are cultured under conditions that promote the expression of the gG protein.
  4. Protein Purification: The recombinant gG protein is purified from the host cells using various techniques, such as affinity chromatography, to obtain a high-purity product.
Applications and Significance

The use of recombinant gG has several significant applications:

  1. Improved Diagnostics: Recombinant gG-based assays provide high specificity and sensitivity for detecting HSV-2 infections, reducing the likelihood of false-positive results.
  2. Vaccine Research: The development of a vaccine against HSV-2 is a high priority in the field of infectious diseases. Recombinant gG is a key component in many experimental vaccines, offering hope for effective prevention of HSV-2 infections.
  3. Understanding Immune Evasion: Studying recombinant gG helps researchers understand how HSV-2 evades the host immune system, leading to better therapeutic strategies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.